Related Experiment Video
Updated: May 1, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Molecular tumorigenesis of the skin
Yoshiaki Kubo1, Yoshihiro Matsudate, Nozomi Fukui
1Department of Dermatology, Institute of Health Biosciences, the University of Tokushima Graduate School.
Abstract:
Skin tumors are supposed to develop through accumulations of genetic and/or epigenetic events in normal cells of the skin. Among them, we focus on common skin tumors, including benign, seborrheic keratosis, and malignant, squamous cell carcinoma and melanoma. Many important molecules have been detected on the molecular tumorigenesis of each of them to date, and some drugs targeted for their molecules have been already developed. We review updates on the molecular tumorigenesis of these tumors with our current works.
Insights
This review details the molecular basis of common skin tumors, including seborrheic keratosis, squamous cell carcinoma, and melanoma. It highlights key molecular events and targeted therapies for skin cancer development.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Skin tumors arise from accumulated genetic and epigenetic alterations in skin cells.
- Common skin tumors include benign seborrheic keratosis and malignant squamous cell carcinoma and melanoma.
- Understanding molecular tumorigenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent advancements in the molecular tumorigenesis of common skin tumors.
- To present current research on the molecular pathways involved in skin cancer development.
- To discuss targeted therapeutic strategies based on molecular findings.
Main Methods:
- Literature review of molecular tumorigenesis in skin cancers.
- Analysis of genetic and epigenetic events in tumor development.
- Synthesis of current research findings and therapeutic targets.
Main Results:
- Key molecular events driving seborrheic keratosis, squamous cell carcinoma, and melanoma have been identified.
- Several molecular targets for therapeutic intervention have been discovered.
- Current research provides insights into the complex molecular landscape of skin tumors.
Conclusions:
- Molecular insights are advancing the understanding and treatment of skin tumors.
- Targeted therapies hold promise for improving outcomes in skin cancer patients.
- Continued research into molecular tumorigenesis is essential for future therapeutic innovations.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Mutagenicity and Carcinogenicity

